National Council for Prescription Drug Programs indexing - billing unit

Manufacturer: National Council for Prescription Drug Programs
Effective date: 2012-07-24
Label type: Indexing - Billing Unit
Version: 1
Source: full-release
Hydrated at: 2026-06-05 01:39:20

Label at a glance#

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0338-0603-04	ML - Milliliter	0338-0603	47c79dda-fa2a-4553-823a-3e742ed168d1	1	2012-07-24

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
0338-0603	0338-0603-04

Source Document#

Source XML

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 8 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
N018629-001	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 5MEQ IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	5GM/100ML;75MG/100ML;330MG/100ML	INJECTABLE / INJECTION	AP	1982-03-23
N018629-002	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	5GM/100ML;150MG/100ML;330MG/100ML	INJECTABLE / INJECTION	AP	1982-03-23
N018629-003	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 15MEQ IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	5GM/100ML;224MG/100ML;330MG/100ML	INJECTABLE / INJECTION	AP	1982-03-23
N018629-004	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	5GM/100ML;150MG/100ML;330MG/100ML	INJECTABLE / INJECTION	AP	1982-03-23
N018629-005	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	5GM/100ML;75MG/100ML;330MG/100ML	INJECTABLE / INJECTION	AP	1982-03-23
N018629-006	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	5GM/100ML;300MG/100ML;330MG/100ML	INJECTABLE / INJECTION	AP	1982-03-23
N018629-007	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 30MEQ IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	5GM/100ML;224MG/100ML;330MG/100ML	INJECTABLE / INJECTION	AP	1982-03-23
N018629-008	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 40MEQ IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	5GM/100ML;300MG/100ML;330MG/100ML	INJECTABLE / INJECTION	AP	1982-03-23

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 8 matching rows.

Application-product, TE code table
Application-product	TE code
N018629-001	AP
N018629-002	AP
N018629-003	AP
N018629-004	AP
N018629-005	AP
N018629-006	AP
N018629-007	AP
N018629-008	AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 9 · 352 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-10-15 13:18:30	2026-09	N018629-001	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 5MEQ IN PLASTIC CONTAINER	5GM/100ML;75MG/100ML;330MG/100ML	INJECTABLE / INJECTION	AP	1982-03-23	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N018629-002	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER	5GM/100ML;150MG/100ML;330MG/100ML	INJECTABLE / INJECTION	AP	1982-03-23	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N018629-003	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 15MEQ IN PLASTIC CONTAINER	5GM/100ML;224MG/100ML;330MG/100ML	INJECTABLE / INJECTION	AP	1982-03-23	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N018629-004	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER	5GM/100ML;150MG/100ML;330MG/100ML	INJECTABLE / INJECTION	AP	1982-03-23	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N018629-005	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER	5GM/100ML;75MG/100ML;330MG/100ML	INJECTABLE / INJECTION	AP	1982-03-23	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N018629-006	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER	5GM/100ML;300MG/100ML;330MG/100ML	INJECTABLE / INJECTION	AP	1982-03-23	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N018629-007	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 30MEQ IN PLASTIC CONTAINER	5GM/100ML;224MG/100ML;330MG/100ML	INJECTABLE / INJECTION	AP	1982-03-23	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N018629-008	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 40MEQ IN PLASTIC CONTAINER	5GM/100ML;300MG/100ML;330MG/100ML	INJECTABLE / INJECTION	AP	1982-03-23	`c2088c7a36db…`
2026-09-14 22:38:34	2026-08	N018629-001	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 5MEQ IN PLASTIC CONTAINER	5GM/100ML;75MG/100ML;330MG/100ML	INJECTABLE / INJECTION	AP	1982-03-23	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N018629-002	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER	5GM/100ML;150MG/100ML;330MG/100ML	INJECTABLE / INJECTION	AP	1982-03-23	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N018629-003	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 15MEQ IN PLASTIC CONTAINER	5GM/100ML;224MG/100ML;330MG/100ML	INJECTABLE / INJECTION	AP	1982-03-23	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N018629-004	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER	5GM/100ML;150MG/100ML;330MG/100ML	INJECTABLE / INJECTION	AP	1982-03-23	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N018629-005	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER	5GM/100ML;75MG/100ML;330MG/100ML	INJECTABLE / INJECTION	AP	1982-03-23	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N018629-006	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER	5GM/100ML;300MG/100ML;330MG/100ML	INJECTABLE / INJECTION	AP	1982-03-23	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N018629-007	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 30MEQ IN PLASTIC CONTAINER	5GM/100ML;224MG/100ML;330MG/100ML	INJECTABLE / INJECTION	AP	1982-03-23	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N018629-008	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 40MEQ IN PLASTIC CONTAINER	5GM/100ML;300MG/100ML;330MG/100ML	INJECTABLE / INJECTION	AP	1982-03-23	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N018629-001	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 5MEQ IN PLASTIC CONTAINER	5GM/100ML;75MG/100ML;330MG/100ML	INJECTABLE / INJECTION	AP	1982-03-23	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N018629-002	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER	5GM/100ML;150MG/100ML;330MG/100ML	INJECTABLE / INJECTION	AP	1982-03-23	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N018629-003	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 15MEQ IN PLASTIC CONTAINER	5GM/100ML;224MG/100ML;330MG/100ML	INJECTABLE / INJECTION	AP	1982-03-23	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N018629-004	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER	5GM/100ML;150MG/100ML;330MG/100ML	INJECTABLE / INJECTION	AP	1982-03-23	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N018629-005	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER	5GM/100ML;75MG/100ML;330MG/100ML	INJECTABLE / INJECTION	AP	1982-03-23	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N018629-006	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER	5GM/100ML;300MG/100ML;330MG/100ML	INJECTABLE / INJECTION	AP	1982-03-23	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N018629-007	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 30MEQ IN PLASTIC CONTAINER	5GM/100ML;224MG/100ML;330MG/100ML	INJECTABLE / INJECTION	AP	1982-03-23	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N018629-008	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 40MEQ IN PLASTIC CONTAINER	5GM/100ML;300MG/100ML;330MG/100ML	INJECTABLE / INJECTION	AP	1982-03-23	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N018629-001	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 5MEQ IN PLASTIC CONTAINER	5GM/100ML;75MG/100ML;330MG/100ML	INJECTABLE / INJECTION	AP	1982-03-23	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N018629-002	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER	5GM/100ML;150MG/100ML;330MG/100ML	INJECTABLE / INJECTION	AP	1982-03-23	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N018629-003	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 15MEQ IN PLASTIC CONTAINER	5GM/100ML;224MG/100ML;330MG/100ML	INJECTABLE / INJECTION	AP	1982-03-23	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N018629-004	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER	5GM/100ML;150MG/100ML;330MG/100ML	INJECTABLE / INJECTION	AP	1982-03-23	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N018629-005	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER	5GM/100ML;75MG/100ML;330MG/100ML	INJECTABLE / INJECTION	AP	1982-03-23	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N018629-006	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER	5GM/100ML;300MG/100ML;330MG/100ML	INJECTABLE / INJECTION	AP	1982-03-23	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N018629-007	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 30MEQ IN PLASTIC CONTAINER	5GM/100ML;224MG/100ML;330MG/100ML	INJECTABLE / INJECTION	AP	1982-03-23	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N018629-008	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 40MEQ IN PLASTIC CONTAINER	5GM/100ML;300MG/100ML;330MG/100ML	INJECTABLE / INJECTION	AP	1982-03-23	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N018629-001	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 5MEQ IN PLASTIC CONTAINER	5GM/100ML;75MG/100ML;330MG/100ML	INJECTABLE / INJECTION	AP	1982-03-23	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N018629-002	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER	5GM/100ML;150MG/100ML;330MG/100ML	INJECTABLE / INJECTION	AP	1982-03-23	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N018629-003	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 15MEQ IN PLASTIC CONTAINER	5GM/100ML;224MG/100ML;330MG/100ML	INJECTABLE / INJECTION	AP	1982-03-23	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N018629-004	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER	5GM/100ML;150MG/100ML;330MG/100ML	INJECTABLE / INJECTION	AP	1982-03-23	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N018629-005	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER	5GM/100ML;75MG/100ML;330MG/100ML	INJECTABLE / INJECTION	AP	1982-03-23	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N018629-006	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER	5GM/100ML;300MG/100ML;330MG/100ML	INJECTABLE / INJECTION	AP	1982-03-23	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N018629-007	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 30MEQ IN PLASTIC CONTAINER	5GM/100ML;224MG/100ML;330MG/100ML	INJECTABLE / INJECTION	AP	1982-03-23	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N018629-008	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 40MEQ IN PLASTIC CONTAINER	5GM/100ML;300MG/100ML;330MG/100ML	INJECTABLE / INJECTION	AP	1982-03-23	`31067a03dcf5…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 9 · 352 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-10-15 13:18:30	2026-09	N018629-001	AP	1	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N018629-002	AP	1	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N018629-003	AP	1	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N018629-004	AP	1	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N018629-005	AP	1	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N018629-006	AP	1	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N018629-007	AP	1	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N018629-008	AP	1	`c2088c7a36db…`
2026-09-14 22:38:34	2026-08	N018629-001	AP	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N018629-002	AP	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N018629-003	AP	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N018629-004	AP	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N018629-005	AP	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N018629-006	AP	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N018629-007	AP	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N018629-008	AP	1	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N018629-001	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N018629-002	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N018629-003	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N018629-004	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N018629-005	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N018629-006	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N018629-007	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N018629-008	AP	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N018629-001	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N018629-002	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N018629-003	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N018629-004	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N018629-005	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N018629-006	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N018629-007	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N018629-008	AP	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N018629-001	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N018629-002	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N018629-003	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N018629-004	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N018629-005	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N018629-006	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N018629-007	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N018629-008	AP	1	`31067a03dcf5…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.